Biotalys NV (EBR:BTLS)

Market Cap	107.30M -21.1%
Revenue (ttm)	n/a
Net Income	-14.83M
EPS	-0.42
Shares Out	37.52M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,560
Average Volume	64,055
Open	2.930
Previous Close	2.960
Day's Range	2.800 - 2.930
52-Week Range	2.480 - 5.500
Beta	0.86
RSI	38.50
Earnings Date	Mar 12, 2026

About Biotalys NV

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2013
• Employees: 63
• Stock Exchange: Euronext Brussels
• Ticker Symbol: BTLS